Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Interest & Investment Income (2016 - 2021)

Palisade Bio has reported Interest & Investment Income over the past 12 years, most recently at $3917.0 for Q1 2021.

  • Quarterly Interest & Investment Income fell 70.52% to $3917.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $24160.0 through Mar 2021, down 53.56% year-over-year, with the annual reading at $33532.0 for FY2020, 50.49% down from the prior year.
  • Interest & Investment Income was $3917.0 for Q1 2021 at Palisade Bio, down from $5597.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $29000.0 in Q1 2019 and troughed at $3917.0 in Q1 2021.
  • The 5-year median for Interest & Investment Income is $15234.0 (2019), against an average of $14954.6.
  • Year-over-year, Interest & Investment Income skyrocketed 87.53% in 2017 and then crashed 70.52% in 2021.
  • A 5-year view of Interest & Investment Income shows it stood at $17274.0 in 2017, then skyrocketed by 38.35% to $23898.0 in 2018, then plummeted by 47.09% to $12645.0 in 2019, then tumbled by 55.74% to $5597.0 in 2020, then plummeted by 30.02% to $3917.0 in 2021.
  • Per Business Quant, the three most recent readings for PALI's Interest & Investment Income are $3917.0 (Q1 2021), $5597.0 (Q4 2020), and $7731.0 (Q3 2020).